Sg Americas Securities, LLC Bio Atla, Inc. Transaction History

Sg Americas Securities, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 06, 2024	SELL	$1.88 - $3.46 $18,031 - $33,184	-9,591 Reduced 42.33%	13,069 $45,000
Q4 2023 Jan 12, 2024	BUY	$1.27 - $3.18 $885 - $2,216	697 Added 3.17%	22,660 $56,000
Q3 2023 Oct 13, 2023	BUY	$1.7 - $3.07 $37,337 - $67,426	21,963 New	21,963 $37,000
Q2 2022 Jul 29, 2022	SELL	$2.13 - $5.38 $28,806 - $72,759	-13,524 Closed	0 $0
Q1 2022 Apr 29, 2022	BUY	$4.38 - $18.78 $36,883 - $158,146	8,421 Added 165.02%	13,524 $68,000
Q4 2021 Feb 07, 2022	SELL	$19.0 - $30.95 $17,328 - $28,226	-912 Reduced 15.16%	5,103 $100,000
Q3 2021 Nov 01, 2021	BUY	$29.44 - $43.74 $177,081 - $263,096	6,015 New	6,015 $177,000
Q1 2021 May 13, 2021	SELL	$32.41 - $70.91 $382,437 - $836,738	-11,800 Closed	0 $0
Q4 2020 Feb 04, 2021	BUY	$31.02 - $35.16 $366,036 - $414,887	11,800 New	11,800 $401,000

17.4M

500

33.5K

Ticker BCAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,304,100
Market Cap $16.7M
Description
BioAtla, Inc., a clinical stage biopharmaceutical company, develops specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its lead product candidate is BA3011, a conditionally active biologic (CAB) antibody-drug conjugate (ADC) for soft tissue and bone sarcoma tumors, non-small cell lung cancer (NSCLC), and ...

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg Americas Securities, LLC with notifications on news.